ARTICLE | Company News
Visiogen, Abbott deal
September 7, 2009 7:00 AM UTC
Abbott will acquire ophthalmic medical device company Visiogen for $400 million in cash. Visiogen markets its Synchrony dual-optic accommodating intraocular lens (IOL) in Europe to treat presbyopia in...